These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7885621)

  • 1. Sucrose permeability as a marker for nonsteroidal anti-inflammatory gastroduodenal injury: how sweet is it?
    DeMeo M
    Nutr Rev; 1995 Jan; 53(1):13-6. PubMed ID: 7885621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ulcers and gastritis.
    Kashiwagi H
    Endoscopy; 2003 Jan; 35(1):9-14. PubMed ID: 12510220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sucrose permeability as a marker for NSAID-induced gastroduodenal injury.
    Erlacher L; Wyatt J; Pflugbeil S; Köller M; Ullrich R; Vogelsang H; Smolen JS; Graninger W
    Clin Exp Rheumatol; 1998; 16(1):69-71. PubMed ID: 9543566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastroduodenal complications of chronic NSAID therapy.
    Graham DY; Smith JL
    Am J Gastroenterol; 1988 Oct; 83(10):1081-4. PubMed ID: 3048080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic imaging of NSAID ulcers].
    Ono S; Kato M; Asaka M; Ono Y; Yokoyama A
    Nihon Rinsho; 2007 Oct; 65(10):1792-800. PubMed ID: 17926526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple, non-invasive marker of gastric damage: sucrose permeability.
    Sutherland LR; Verhoef M; Wallace JL; Van Rosendaal G; Crutcher R; Meddings JB
    Lancet; 1994 Apr; 343(8904):998-1000. PubMed ID: 7909091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events.
    Hunt RH; Harper S; Watson DJ; Yu C; Quan H; Lee M; Evans JK; Oxenius B
    Am J Gastroenterol; 2003 Aug; 98(8):1725-33. PubMed ID: 12907325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal anti-inflammatory drugs and gastrointestinal disease: pathophysiology, treatment and prevention.
    Bjorkman DJ; Kimmey MB
    Dig Dis; 1995; 13(2):119-29. PubMed ID: 7586632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal anti-inflammatory drugs and gastroduodenal injury.
    Venkat K; Brown MD; Barkin R
    Am J Ther; 1998 Jul; 5(4):263-72. PubMed ID: 10099068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications.
    Goldstein JL; Howard KB; Walton SM; McLaughlin TP; Kruzikas DT
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of nonsteroidal antiinflammatory drug-induced gastroduodenal injury in children with juvenile rheumatoid arthritis.
    Mulberg AE; Linz C; Bern E; Tucker L; Verhave M; Grand RJ
    J Pediatr; 1993 Apr; 122(4):647-9. PubMed ID: 8463919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal anti-inflammatory drug gastropathy.
    Laine L
    Gastrointest Endosc Clin N Am; 1996 Jul; 6(3):489-504. PubMed ID: 8803564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of NSAID induced peptic ulcer disease.
    Hamid S; Yakoob J; Jafri W; Islam S; Abid S; Islam M
    J Pak Med Assoc; 2006 May; 56(5):218-22. PubMed ID: 16767948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between nonsteroidal anti-inflammatory drug use and peptic ulcer disease.
    Graham DY
    Gastroenterol Clin North Am; 1990 Mar; 19(1):171-82. PubMed ID: 2184127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nonsteroidal Anti-inflammatory Drug and Aspirin-induced Peptic Ulcer Disease].
    Shim YK; Kim N
    Korean J Gastroenterol; 2016 Jun; 67(6):300-12. PubMed ID: 27312830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsteroidal anti-inflammatory drugs, cyclooxygenase inhibitors, and the risk of gastrointestinal complications.
    Cheskin LJ
    Am J Manag Care; 2001 Sep; 7(12 Suppl):S395-6. PubMed ID: 11570030
    [No Abstract]   [Full Text] [Related]  

  • 18. NSAID-induced mucosal injury.
    Liebowitz D
    J Clin Gastroenterol; 1988 Dec; 10(6):609-11. PubMed ID: 3230276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal bleeding associated with the use of non-steroidal, anti-inflammatory drugs--symptomatology and clinical course.
    Aabakken L; Weberg R; Lygren I; Eidsvoll B; Stray N; Osnes M
    Agents Actions; 1992; Spec No():C86-7. PubMed ID: 1442342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-steroidal anti-inflammatory drugs use and risk of upper gastrointestinal adverse events in cirrhotic patients.
    Lee YC; Chang CH; Lin JW; Chen HC; Lin MS; Lai MS
    Liver Int; 2012 May; 32(5):859-66. PubMed ID: 22226322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.